Plasma therapy is one of several different experimental longevity procedures that involve blood transfers, including platelet ...

While the EU Commission seeks to reduce strategic dependencies, Europe continues to import nearly a third of its blood plasma ...

A wave of diagnostic tests—some here, some coming—can identify cancer and Alzheimer’s at earlier stages and predict flare-ups ...

Researchers evaluated a fully automated plasma biomarker panel to detect early amyloid-β accumulation in cognitively ...

The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, making the test the first to get signoff to aid in the early detection of the ...

Isavuconazole, an antimycotic agent used to treat fungal infections, can typically be found during dried blood spot sampling.

The man kept getting worse; in fact, he seemed to deteriorate before their eyes. Initially, he received supplemental oxygen ...

Participants in the highest BGAT quartile of this study had a hazard ratio for VTE risk of 2.12 compared with those in the lowest BGAT quartile after adjusting for age and sex characteristics.

The exponential interest in neurology blood-based biomarkers stems from the technical breakthroughs in testing brought about ...

The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.

It works by measuring two proteins in blood plasma: pTau217 and beta-amyloid 1-42. A ratio of those proteins tends to correlate with the occurrence or absence of amyloid plaques in the brain ...

The FDA has granted 510(k) marketing clearance to the first in vitro blood-based biomarker diagnostic device for Alzheimer’s ...